跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Spotclav 625
Approved
STANDARD
Spotclav 625
Sparsh Bio-Tech Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
34a4726e0578fb6a
Company
Sparsh Bio-Tech Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
34a4726e0578fb6a
Drug Approval Philippines Name
Spotclav 625
Product Name
Spotclav 625
Registration Number
DR-XY48788
Brand Name
Spotclav 625
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablets
Dosage Strength
625mg
Manufacturer
Sparsh Bio-Tech Pvt. Ltd.
Importer
Khriz Pharma Trading Inc.
Distributor
Khriz Pharma Trading Inc.
Issuance Date
29 June 2023
Expiry Date
29 June 2028
Pharmacologic Category
Combination of Penicillin, Incl. Beta-Lactamse Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
34a4726e0578fb6a
Type
Standard
Back to Philippines FDA Approvals
Spotclav 625 - Philippines FDA Drug Approval Details